World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
133
Citations
84485
World Ranking
2187
National Ranking
107

Overview

Kai-Uwe Eckardt is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily focuses on nephrology within the broader field of medicine, with significant contributions in areas such as chronic kidney disease, dialysis, and renal disease management.

The scientist's main fields of study include:

  • Medicine

Within medicine, their subfields of interest cover:

  • Nephrology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Infectious Diseases
  • Genetics

Their research topics reveal a concentration on:

  • Chronic Kidney Disease and Diabetes
  • Dialysis and Renal Disease Management
  • COVID-19 Clinical Research Studies
  • Erythropoietin and Anemia Treatment
  • Renal Diseases and Glomerulopathies
  • SARS-CoV-2 and COVID-19 Research
  • Renal and Vascular Pathologies

The researcher has published extensively in several prominent scientific venues, including:

  • Nephrology Dialysis Transplantation
  • Journal of the American Society of Nephrology
  • Kidney International
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Kidney International Reports

Frequent collaborators include:

  • Ulla T. Schultheiß
  • Anna Köttgen
  • Florian Kronenberg
  • Wolfgang C. Winkelmayer
  • Fruzsina Kotsis

Recent notable publications by Kai-Uwe Eckardt cover a variety of topics in nephrology and COVID-19 research. Selected papers are:

  • "Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference," 2020, Kidney International
  • "Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients," 2021, Science Immunology
  • "Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection," 2021, Nature Reviews Nephrology
  • "High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms," 2020, Brain Behavior and Immunity
  • "Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD," 2021, New England Journal of Medicine

Best Publications

  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

    Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward

  • Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

    Andrew S. Levey;Kai-Uwe Eckardt;Yusuke Tsukamoto;Adeera Levin

  • The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

    Andrew S. Levey;Paul E. de Jong;Josef Coresh;Meguid E.l. Nahas

  • Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

    Tilman B. Drüeke;Francesco Locatelli;Naomi Clyne;Kai-Uwe Eckardt

  • A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper

  • Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

    A.S. Levey;R. Atkins;J. Coresh;E.P. Cohen

  • Evolving importance of kidney disease: from subspecialty to global health burden

    Kai Uwe Eckardt;Josef Coresh;Olivier Devuyst;Richard J. Johnson

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality.: A collaborative meta-analysis of high-risk population cohorts

    Marije van der Velde;Kunihiro Matsushita;Josef Coresh;Brad C. Astor

  • Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition

    Debra F. Higgins;Kuniko Kimura;Wanja M. Bernhardt;Nikita Shrimanker

  • Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

    Charles A. Herzog;Charles A. Herzog;Richard W. Asinger;Richard W. Asinger;Alan K. Berger;David M. Charytan

  • Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism

    Agnes Machnik;Wolfgang Neuhofer;Jonathan Jantsch;Anke Dahlmann

  • Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

    Francesco Locatelli;Pedro Aljama;Peter Bárány;Bernard Canaud

  • Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome

    Francesco Locatelli;Bernard Canaud;Kai-Uwe Eckardt;Peter Stenvinkel

  • Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    Adeera Levin;Marcello Tonelli;Joseph Bonventre;Josef Coresh

  • Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs.

    Michael S Wiesener;Jan Steffen Jürgensen;Christian Rosenberger;Charlotte K Scholze

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

    Brad C. Astor;Kunihiro Matsushita;Ron T. Gansevoort;Marije Van Der Velde

  • Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha.

    M.S. Wiesener;H. Turley;H. Turley;William Allen;William Allen;C. Willam;C. Willam

  • KDIGO Clinical Practice Guideline for Glomerulonephritis

    Kai-Uwe Eckardt;Bertram L Kasiske

  • Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys.

    Christian Rosenberger;Stefano Mandriota;Jan Steffen Jürgensen;Michael S. Wiesener

  • The burden of kidney disease: Improving global outcomes

    Garabed Eknoyan;Norbert Lameire;Rashad Barsoum;Kai-Uwe Eckardt

Frequent Co-Authors

Armin Kurtz
Armin Kurtz University of Regensburg
Andrew S. Levey
Andrew S. Levey Tufts Medical Center
Florian Kronenberg
Florian Kronenberg Innsbruck Medical University
Anna Köttgen
Anna Köttgen University of Freiburg
Wolfgang C. Winkelmayer
Wolfgang C. Winkelmayer Baylor College of Medicine
David C. Wheeler
David C. Wheeler University College London
Kerstin Amann
Kerstin Amann University of Erlangen-Nuremberg
Iain C. Macdougall
Iain C. Macdougall King's College London
Christoph Wanner
Christoph Wanner University of Würzburg
Jürgen Floege
Jürgen Floege RWTH Aachen University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or complementary career paths, online degrees offer flexible and affordable options. Careers in healthcare administration, pharmacy, and advanced nursing are in high demand, and many reputable universities now offer accredited online programs.

If you're considering the management side of healthcare, pursuing a health administration degree online can lead to roles in hospital administration or healthcare consulting. The cost of mha degree programs varies widely, so researching affordable options is key for long-term financial planning.

For nurses aiming to advance their careers, exploring the cheapest dnp programs online can help maximize your credentials without a significant financial burden. Likewise, if you are interested in becoming a pharmacist, online education options such as a pharmacy degree online make this pathway more accessible than ever.

Exploring these related online programs can open doors to rewarding careers in healthcare beyond traditional medicine, all while providing flexibility and potential savings.

Best Scientists Citing Kai-Uwe Eckardt

Trending Scientists

Recently Published Articles